Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
MIRM · NASDAQ · Pharmaceutical Preparations
Mirum Pharmaceuticals (MIRM) · oqro.io/stocks/MIRM · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$96.13+0.62 (+0.65%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Planned sale · Planned for Nov 20, 2026 · Notice filed Nov 20, 2026
Officer filed to sell about $1.94M of MIRM stockSourceInsider trade · Traded Nov 16, 2026 · Filed Nov 17, 2026
Director sold ~$185K of MIRM shares in the open marketSourcePlanned sale · Planned for Nov 16, 2026 · Notice filed Nov 16, 2026
Director filed to sell about $185K of MIRM stockSourceInsider trade · Traded Nov 11, 2026 · Filed Nov 13, 2026
Director sold ~$1.03M of MIRM shares in the open marketSourceInsider trade · Traded Nov 11, 2026 · Filed Nov 13, 2026
Director sold ~$309K of MIRM shares in the open marketSourcePlanned sale · Planned for Nov 11, 2026 · Notice filed Nov 12, 2026
Director filed to sell about $1.33M of MIRM stockSourceInsider trade · Traded Nov 4, 2026 · Filed Nov 5, 2026
CEO sold ~$1.8M of MIRM shares in the open marketSourcePlanned sale · Planned for Nov 4, 2026 · Notice filed Nov 4, 2026
Officer filed to sell about $1.8M of MIRM stockSourcePlanned sale · Planned for Nov 4, 2026 · Notice filed Nov 4, 2026
Officer filed to sell about $1.42M of MIRM stockSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Paradigm Biocapital Advisors LP no longer reported MIRM for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Eventide Asset Management, LLC disclosed a reduced position in MIRM for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Voleon Capital Management LP disclosed a reduced position in MIRM for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Hood River Capital Management LLC disclosed an increased position in MIRM for Q2 2026Fund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 29, 2026
Perceptive Advisors LLC no longer reported MIRM for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Frazier Life Sciences Management, L.P. disclosed an increased position in MIRM for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Paradigm Biocapital Advisors LP disclosed a new position in MIRM for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Ra Capital Management, L.P. disclosed a new position in MIRM for Q1 2026Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Perceptive Advisors LLC disclosed a new position in MIRM for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Voleon Capital Management LP disclosed an increased position in MIRM for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Polar Capital Holdings Plc disclosed a reduced position in MIRM for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Eventide Asset Management, LLC disclosed a reduced position in MIRM for Q4 2025Fund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Eventide Asset Management, LLC disclosed a reduced position in MIRM for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Polar Capital Holdings Plc disclosed a reduced position in MIRM for Q3 2025SourceInsider trade · Traded Sep 11, 2025 · Filed Sep 13, 2025
Director sold ~$1.15M of MIRM shares in the open marketSourceInsider trade · Traded Sep 12, 2025 · Filed Sep 13, 2025
CFO sold ~$728K of MIRM shares in the open marketSourceInsider trade · Traded Sep 11, 2025 · Filed Sep 13, 2025
Director sold ~$112K of MIRM shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Eventide Asset Management, LLC disclosed an increased position in MIRM for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Polar Capital Holdings Plc disclosed a reduced position in MIRM for Q2 2025SourceInsider trade · Traded Aug 11, 2025 · Filed Aug 12, 2025
CEO sold ~$2.48M of MIRM shares in the open marketSourceInsider trade · Traded Aug 7, 2025 · Filed Aug 8, 2025
CEO sold ~$2.21M of MIRM shares in the open marketSourceInsider trade · Traded Jul 2, 2025 · Filed Jul 3, 2025
Officer sold ~$27K of MIRM shares in the open marketSourceInsider trade · Traded Jul 3, 2025 · Filed Jul 3, 2025
Officer sold ~$23K of MIRM shares in the open marketSourceInsider trade · Traded Jun 11, 2025 · Filed Jun 13, 2025
Director sold ~$155K of MIRM shares in the open marketSourceInsider trade · Traded Jun 2, 2025 · Filed Jun 4, 2025
Director sold ~$263K of MIRM shares in the open marketSourceInsider trade · Traded Jun 3, 2025 · Filed Jun 4, 2025
Director sold ~$114K of MIRM shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Frazier Life Sciences Management, L.P. disclosed an increased position in MIRM for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Eventide Asset Management, LLC disclosed a reduced position in MIRM for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Polar Capital Holdings Plc disclosed an increased position in MIRM for Q1 2025SourceInsider trade · Traded Mar 17, 2025 · Filed Mar 19, 2025
CEO sold ~$1.21M of MIRM shares in the open marketSourceInsider trade · Traded Mar 17, 2025 · Filed Mar 19, 2025
Officer sold ~$2.22M of MIRM shares in the open marketSourceInsider trade · Traded Mar 17, 2025 · Filed Mar 19, 2025
Officer sold ~$348K of MIRM shares in the open marketSourceInsider trade · Traded Mar 17, 2025 · Filed Mar 19, 2025
Officer sold ~$128K of MIRM shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Eventide Asset Management, LLC disclosed a reduced position in MIRM for Q4 2024SourceInsider trade · Traded Feb 3, 2025 · Filed Feb 4, 2025
CEO sold ~$439K of MIRM shares in the open marketSourceInsider trade · Traded Feb 3, 2025 · Filed Feb 4, 2025
Officer sold ~$127K of MIRM shares in the open marketSourceInsider trade · Traded Feb 3, 2025 · Filed Feb 4, 2025
Officer sold ~$51K of MIRM shares in the open marketSourceInsider trade · Traded Jan 24, 2025 · Filed Jan 27, 2025
CEO sold ~$328K of MIRM shares in the open marketSourceInsider trade · Traded Jan 24, 2025 · Filed Jan 27, 2025
Officer sold ~$152K of MIRM shares in the open marketSourceInsider trade · Traded Jan 24, 2025 · Filed Jan 27, 2025
Officer sold ~$43K of MIRM shares in the open marketSourceInsider trade · Traded Jan 17, 2025 · Filed Jan 21, 2025
Officer sold ~$320K of MIRM shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 15, 2024
Frazier Life Sciences Management, L.P. disclosed an increased position in MIRM for Q3 2024SourceInsider trade · Traded Nov 14, 2024 · Filed Nov 15, 2024
Officer sold ~$118K of MIRM shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Eventide Asset Management, LLC disclosed a reduced position in MIRM for Q3 2024SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
William Blair Investment Management, LLC disclosed an increased position in MIRM for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
Segall Bryant & Hamill, LLC disclosed an increased position in MIRM for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Eventide Asset Management, LLC disclosed a reduced position in MIRM for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Voleon Capital Management LP disclosed a reduced position in MIRM for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Hood River Capital Management LLC disclosed an increased position in MIRM for Q1 2026SourceInsider trade · Traded Aug 7, 2025 · Filed Aug 8, 2025
Officer sold ~$580K of MIRM shares in the open marketSourceInsider trade · Traded Mar 17, 2025 · Filed Mar 19, 2025
Officer sold ~$125K of MIRM shares in the open marketSourceInsider trade · Traded Mar 18, 2025 · Filed Mar 19, 2025
Officer sold ~$107K of MIRM shares in the open marketSourceInsider trade · Traded Mar 17, 2025 · Filed Mar 19, 2025
Officer sold ~$80K of MIRM shares in the open marketSourceInsider trade · Traded Mar 14, 2025 · Filed Mar 18, 2025
Director purchased ~$23K of MIRM shares in the open marketSourceInsider trade · Traded Mar 17, 2025 · Filed Mar 18, 2025
Director purchased ~$923 of MIRM shares in the open marketSourceInsider trade · Traded Mar 11, 2025 · Filed Mar 12, 2025
Director purchased ~$42K of MIRM shares in the open marketSourceInsider trade · Traded Mar 10, 2025 · Filed Mar 12, 2025
Director purchased ~$32K of MIRM shares in the open marketSourceInsider trade · Traded Mar 10, 2025 · Filed Mar 12, 2025
Director purchased ~$25K of MIRM shares in the open marketSourceInsider trade · Traded Mar 6, 2025 · Filed Mar 10, 2025
Director purchased ~$59K of MIRM shares in the open marketSourceInsider trade · Traded Mar 7, 2025 · Filed Mar 10, 2025
Director purchased ~$25K of MIRM shares in the open marketSourceInsider trade · Traded Mar 4, 2025 · Filed Mar 6, 2025
Director purchased ~$58K of MIRM shares in the open marketSourceInsider trade · Traded Mar 5, 2025 · Filed Mar 6, 2025
Director purchased ~$12K of MIRM shares in the open marketSourceInsider trade · Traded Mar 4, 2025 · Filed Mar 6, 2025
Director purchased ~$2.6K of MIRM shares in the open marketSourceInsider trade · Traded Mar 4, 2025 · Filed Mar 5, 2025
Officer sold ~$623K of MIRM shares in the open marketSourceInsider trade · Traded Mar 4, 2025 · Filed Mar 5, 2025
Officer sold ~$53K of MIRM shares in the open marketSourceInsider trade · Traded Mar 3, 2025 · Filed Mar 4, 2025
CEO sold ~$972K of MIRM shares in the open marketSourceInsider trade · Traded Mar 3, 2025 · Filed Mar 4, 2025
CEO sold ~$904K of MIRM shares in the open marketSourceInsider trade · Traded Jan 7, 2025 · Filed Jan 8, 2025
CEO sold ~$321K of MIRM shares in the open marketSourceInsider trade · Traded Jan 7, 2025 · Filed Jan 8, 2025
Officer sold ~$86K of MIRM shares in the open marketSourceInsider trade · Traded Jan 7, 2025 · Filed Jan 8, 2025
Officer sold ~$32K of MIRM shares in the open marketSource